I agree with everyone that design controls don’t have to kill creativity - it really depends on how teams use them. One idea I haven’t seen mentioned yet is how design controls can work alongside agil...

I agree that multiple design reviews are needed, especially at major milestones like inputs, outputs, and validation. But to answer your question about how to ensure full traceability, I think the key...

I like how you mentioned the importance of using documents like the DID and DSD to turn user needs into measurable specs. Something that also works great for bridging that gap is Quality Function Depl...

One thing I’d add is that CRAs help maintain safety and data integrity not just through monitoring, but through ongoing site training and communication. Even with ICH-GCP standards, different sites va...

I think digital tools and AI are helping find eligible patients faster, but one challenge that still gets overlooked is the actual burden of participating. Even if someone wants to join, things like t...

I feel like biomedical engineers play a more active role in clinical research rather than just a supportive one. Yes, they help design devices and analyze trial results, but they also make sure those ...

Dexcom is another company that has been doing great and growing. It’s a business known for its continuous glucose monitoring (CGM) devices, and has had impressive development in recent years. With the...

I think your description of it as "serious science meets stand-up comedy" is really accurate. Especially for those who are not very knowledgeable about science, storytelling undoubtedly makes complica...

Differentiation can rely less on the product itself in a time where many devices have similar features/functions and more on how businesses use patient outcomes and real-world data to create an engagi...

Your explanation of the transition from LLC to S-Corp to C-Corp is great; it makes a lot of sense, particularly for a business in the medical equipment industry where scalability is important. The pot...

I agree that cash flow, which indicates a company's capacity to continue operating on a daily basis, is frequently more significant than profit. The impact of timing is frequently disregarded, as even...

Although I agree that each ownership structure has advantages, I find it interesting how a company's innovation strategy and risk tolerance can vary depending on whether it’s private or public. The am...

One angle I think hasn’t been mentioned yet is how minor errors can actually reveal the “compliance culture” of a company. Even if labeling or paperwork issues don’t affect the class III device direct...

You both raise great arguments regarding how, depending on the company's resources, the FDA can either encourage or impede innovation. I agree that funding and initiatives like Breakthrough Devices be...

I get what you mean about regulatory sounding repetitive, but I think there’s more to it than just paperwork. If a company wants to sell in different countries, the regulatory team has to figure out h...